The CliniSys Group, the leading supplier in the European market of clinical laboratory information management systems, has today announced that it has acquired the laboratory information system (LIS) business unit of MCS AG, a leading software and consultancy provider for private and public laboratories in Germany and neighbouring countries.
The acquisition will significantly expand the Group’s position in the German market and will enable the Group to offer a broader and deeper range of services and solutions to their customer base across Europe. The CliniSys Group will now have annual revenues in excess of €50 million, and employ more than 350 people at multiple sites. The Group will be supporting over 550 LIS customers with laboratories in over 1,000 locations. This acquisition cements the Group’s leading position across the European laboratory information systems market.
The acquisition of the MCS LIS business will allow us to offer a wider range of products and services to our customers in Germany.
“As a company we are 100% focused on laboratory software, in both the private and public sector; it is this dedication that we believe has helped us to become a market leader across the major European markets. To continue our success, it is vital to stay close to the market and invest in local knowledge. The MCS LIS business will bring to the table its own strong presence and intimate knowledge of the German and German speaking markets. This extended reach and expertise will enable us to develop products to support the future developments of laboratories and their services.”
Fiona Pearson, CEO, CliniSys Group